Enanta Pharmaceuticals | DETTE

Debt Changement Date
AbbVie USD 60.75B 269M 2023-09
Amgen USD 64.61B 4.15B 2023-12
Arrowhead Research USD 263.06M 263.06M 2023-06
AstraZeneca USD 28.58B 1.26B 2023-09
Bristol-Myers Squibb USD 39.77B 2.17B 2023-12
Gilead Sciences USD 24.98B 264M 2023-09
GlaxoSmithKline GBP 20.84B 638M 2023-09
Halozyme Therapeutics USD 1.5B 1.63M 2023-12
Incyte USD 32.6M 678K 2023-12
Insmed USD 1.18B 7.19M 2023-12
Ionis Pharmaceuticals USD 1.27B 14.67M 2023-12
Ligand Pharmaceuticals USD 7K 76.83M 2023-12
Merck USD 34.86B 2.05B 2023-09
Neurocrine Biosciences USD 169.9M 200K 2023-09
Pfizer USD 63.6B 1.74B 2023-09
PTC Therapeutics USD 2.12B 762.21M 2023-12
Roche Holding CHF 25.39B 35M 2023-06
Sarepta Therapeutics USD 1.24B 1.24M 2023-09
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09



Enanta Pharmaceuticals DETTE - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2024.